Early Stage East

2010 Keynote Speaker - Daymond John
Founder & CEO, FUBU - The Collection

Presenting Companies
Vision to Value: Venture Fundamentals in a Day
Keynote Speaker
2010 Award Winner
Venture Industry Annual Update with NVCA
Emerging Media Technologies Panel
Branding Strategies Panel
Travel, Directions & Accomodations

< Back to ESE Press Releases

For Immediate Release
November 14th, 2006

Early Stage East Announces Zev Scherl as Honorary Chair of Bio·Life·Tech Princeton

Princeton, NJ – Early Stage East is pleased to announce that Zev Scherl, General Partner, NewSpring Capital has been named as the Honorary Co-Chair for Bio·Life·Tech Princeton.  

“Bio·Life·Tech is a quality event,” said Scherl.  “NewSpring has invested in Bio·Life·Tech 2005 ‘alums', and we are looking forward to working with the next generation of Bio·Life·Tech CEOs and companies.”  

“We are thrilled to have Zev Scherl and NewSpring involved in Bio·Life·Tech this year,” said Amy Aiq, Director of Early Stage East. “Traditionally we have held our Bio·Life·Tech event in the life science corridor in the southern end of our footprint.  We are looking forward to having some of our New York partners, including NewSpring, more involved this year.”

Bio·Life·Tech focuses on early stage companies involved in life science, biotechnology, pharmaceutical, medical instrumentation and the related emerging technologies. The conference will bring 200+ entrepreneurs, CEO's, VC's and investors together in one the East Coast's hot beds of life science innovation and investment. For more information about Bio•Life•Tech Princeton visit www.biolifetech.org email us at [email protected] or phone 302.777.2460.

About Zev Scherl

Mr. Scherl is a General Partner of NewSpring Capital, with significant experience in principal investing, corporate management and finance, focused exclusively in the life sciences and healthcare industries.   Mr. Scherl is currently a board member of AppTec Laboratory Services, Inc., EKR Therapeutics, Immune Control, Nitric Bio Therapeutics, and Scandius BioMedical, Inc.

About NewSpring Capital

NewSpring Capital is a private equity family of funds providing capital for growth and expansion stage companies in the business services, healthcare & life sciences and information technology sectors.

NewSpring Capital combines deep operating knowledge with financial and investing expertise to provide growing companies the financial resources, advice, network of contacts and strategic partnerships necessary to be successful.

About Early Stage East

Early Stage East is an organization dedicated to seeing early stage companies grow and succeed. Early Stage East was founded in 1998 as a non-profit organization and has grown from a single-day venture capital fair to a year-round series of events that include venture conferences and entrepreneurial education programs. Our events showcase entrepreneurs from up and down the East Coast, allowing them to effectively obtain venture capital and successfully start break-away businesses. Early Stage East is geographically the largest venture conference tailored specifically for early stage companies. Companies that have participated in Early Stage East events have gone on to raise over $600 million in institutional funding.


ESE Newsletter

Press Archive

Press Release
Archive hosted by PR Newswire